Join
Live feed
·
PRReleasevia Quantisnow
Pressure BioSciences, Inc. logo

Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue

ByQuantisnow·Wall Street's wire, on your screen.
PBIO· Pressure BioSciences, Inc.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBIO (Pressure BioSciences, Inc.) and more on Quantisnow.